Little is known about the natural history of ductal carcinoma in-situ (DCIS). Estimates from studies of recurrence following surgery suggest about 30% recur as invasive cancer. The aim of this study is to use novel applications of statistical methods to estimate the proportion of DCIS that progress to invasive cancer. We first analysed observed screening data and showed that neither time since previous negative screen or HRT use were associated ...